Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Clinically isolated syndromes and the relationship to multiple sclerosis.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
Recommendations for diagnosis and management of multiple sclerosis.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury.
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon Beta-1a in patients with multiple sclerosis.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Naltrexone
Multi-compartment t2 relaxometry using a spatially constrained multi-gaussian model.
Multiple Sclerosis: Changes in Microarchitecture of White Matter Tracts after Training with a Video Game Balance Board.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment.
[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis.]
Astrocytes Underlie Neuroinflammatory Memory Impairment.
Pages
« first
‹ previous
…
173
174
175
176
177
178
179
180
181
…
next ›
last »